Human growth hormone drugs market dominated by the US due to an emergence of approved products

Press Release   •   Oct 24, 2012 10:25 BST

The human growth hormone drugs market has been forecast to reach a market value of $4.7 billion by the year 2018, with the industry being predominantly driven by the high prevalence of growth hormone deficiency, improved delivery devices, development of novel drug delivery methods, and increasing indications of growth hormones.

Human growth hormones are a naturally occurring protein hormone produced by the pituitary gland and are important for normal human growth and development, especially in children and teenagers. Low human growth hormone levels in children and teenagers result in dwarfism. Excessive human growth hormone levels increase muscle mass by stimulating protein synthesis, strengthen bones by stimulating bone growth and reduce body fat by stimulating the breakdown of fat cells. Use of human growth hormone drugs has become increasingly popular as they are so difficult to detect.

Human growth hormone products cater to two different markets - the vanity market and the treatment of growth hormone deficiency. Products targeting the vanity market are non-prescription drugs, which are primarily targeted for use in adults to enhance physical performance or in checking the aging process. On the other side, prescription human growth hormone products are targeted for use in both adults and children, mainly for the treatment of growth hormone deficiency.

Excessive human growth hormones in the body can cause acromegaly, a disease where the hands become spade-like in appearance as they get bigger. Growth of the facial bones causes the face to change shape too. Organs like the heart, liver and kidneys will also undergo excessive growth, leading to potentially life-threatening problems - one of which is cardiomyopathy, a disease of the heart muscle.

The US represents the largest region within the global human growth hormone drugs market. Demand for human growth hormone products began to surge in the US after the US FDA began granting approvals for new human growth hormone products. The emergence of approved products, especially for specific indications, led to a substantial increase in the number of patients diagnosed with these conditions.

For more information on the human growth hormone drugs market, see the latest research: Human Growth Hormone Drugs Market

Follow us on Twitter @CandMResearch issues news updates and report summaries covering all major industries and sectors. The service provides additional client monitoring and timely alerts to breaking industry and sector news leading the day's business headlines. News articles, written by our staff, contain additional analyst insight, providing value added insight for our readers. News updates and real-time alerts on newly-released market reports are also available from our Facebook page, Twitter feed @CandMResearch and RSS links. We also welcome inquiries from business journalists and the news media.